Background. Coronary revascularization trials often use a composite endpoint of major adverse cardiac and cerebrovascular events (MACCE). The usual practice in analyzing data with a composite endpoint is to assign equal weights to each of the individual MACCE elements. Noninferiority margins are used to offset effects of presumably less important components, but their magnitudes are subject to bias. This study describes the relative importance of MACCE elements from a patient perspective.
Background. Coronary revascularization trials often use a composite endpoint of major adverse cardiac and cerebrovascular events (MACCE). The usual practice in analyzing data with a composite endpoint is to assign equal weights to each of the individual MACCE elements. Noninferiority margins are used to offset effects of presumably less important components, but their magnitudes are subject to bias. This study describes the relative importance of MACCE elements from a patient perspective.
Methods. A discrete choice experiment was conducted. Survey respondents were presented with a scenario that would make them eligible for the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial three-vessel disease cohort. Respondents chose among pairs of procedures that differed on the 3-year probability of MACCE, potential for increased longevity, and procedure/recovery time. Conjoint analysis derived relative weights for these attributes.
Results. In all, 224 respondents completed the survey. The attributes did not have equal weight. Risk of death was most important (relative weight 0.23), followed by stroke (0.18), potential increased longevity and recovery time (each 0.17), myocardial infarction (0.14), and risk of repeat revascularization (0.11). Applying these weights to the SYNTAX 3-year endpoints resulted in a persistent, but decreased margin of difference in MACCE favoring coronary artery bypass graft surgery compared to percutaneous coronary intervention. When labeled only as "procedure A" and "procedure B," 87% of respondents chose coronary artery bypass graft surgery over percutaneous coronary intervention. When procedures were labeled as "coronary stent" and "coronary bypass surgery," only 73% chose coronary artery bypass graft surgery. Procedural preference varied with demographics, sex, and familiarity with the procedures.
Conclusions. The MACCE elements do not carry equal weight in a composite endpoint, from a patient perspective. Using a weighted composite endpoint increases the validity of statistical analyses and trial conclusions. Patients are subject to bias by labels when considering coronary revascularization. [1] . A key practice in using a composite endpoint, however, is that the individual components have equal importance and therefore equal weight. If this practice misses important differences in the relative weights among MACCE components, then the trial statistics, and possibly conclusions, may be misleading. Because trial sponsors and readers all have inherent bias, study conclusions based upon MACCE may be distorted by selective emphasis of one MACCE component or another when actual evidence for the relationships is lacking.
Patients choose among medical treatments based on their personal value systems and their providers' recommendations. To date, no studies have been conducted to determine the relative weights and importance of the components of MACCE. One method to elicit patient preferences is conjoint analysis, a statistical technique using discrete choice experiments traditionally used in marketing studies. In this study, participants chose be-tween procedures that differed with respect to the MACCE endpoints. The conjoint analysis estimates the relative weights of attributes; in this case, the MACCE events associated with coronary revascularization procedures. These weights are then applied to determine if nonequal weights produce different conclusions.
Patients and Methods
A discrete choice experiment was conducted to define the relevance and relative weights of four MACCE elements and two other considerations in coronary revascularization. These results were applied to the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial to illustrate the importance of considering individual element weights in a real-world setting. In addition, the experiment tested whether choices for coronary revascularization procedures are influenced by labels and prior experiences. The National Heart, Lung, and Blood Institute (NHLBI) Cardiothoracic Surgical Trials Network sponsored this study, and the Duke University Medical Center Institutional Review Board approved the survey and research protocols (Pro00027452).
Survey respondents were members of an online panel recruited by Knowledge Networks Inc, and reflective of a location-based representative sample covering 97% of US households [2] . Inclusion criteria for the study were age greater than 18 years and self-reported history at least one of the following: hypertension, hypercholesterolemia, coronary artery disease, congestive heart failure, cardiac arrhythmia, angina, previous myocardial infarction, and peripheral vascular disease. After introductory questions regarding respondents' overall health state, respondents reported their use of cardiac-related medications such as antihypertensive and cholesterollowering drugs. Respondents were then asked to imagine, in lay terms, that they had a "serious heart condition" with symptoms of angina and a subsequent diagnosis of three-vessel coronary disease, and that there was a risk of sudden death without undergoing a "procedure." Then they indicated their familiarity with concepts such as procedure-related hospitalization, stroke, myocardial infarction, and risk of revascularization. Descriptions of stroke and "heart attack" were provided to the respondents in the questions gauging their familiarity with these concepts.
The choice experiment presented respondents with 13 choices between of pairs of unlabeled procedures defined by six attributes. The attributes encompassed all of the clinical considerations in coronary revascularization: risk of death, stroke, myocardial infarction, and repeat revascularization within 3 years; extent of procedure and recovery; and potential for increased longevity. The extent of procedure and recovery were described as duration of the procedure (hours), number of nights in the hospital, and number of weeks needed to recover at home. For the MACCE elements, attribute levels were approximated using 3-year results from the SYNTAX left main or threevessel disease cohort or both [3] . Table 1 lists the attributes and levels included in the conjoint task.
The last two choice tasks asked respondents to choose between PCI and CABG-first unlabeled, then labeledwith the actual attribute levels for each procedure. Survey results were analyzed using Sawtooth software, using hierarchical Bayes modeling, to generate the individuallevel conjoint weights that best reproduce each respondent's choices [4] . The results across questions were generated using IBM SPSS statistical software (SPSS, Chicago, IL).
The relative weights of the attributes were then applied to the SYNTAX 3-year outcome data for the three-vessel disease cohort. For the elements of the SYNTAX composite endpoint, the relative weight was normalized to the average weight of the four MACCE elements to create an adjustment factor. This factor was then multiplied by the measured difference between procedural outcomes to adjust that difference for the measured patient preference.
Results
Of 225 persons screened for the survey, 224 (84 women and 140 men) met the eligibility criteria and completed the online survey. Table 2 shows the baseline demographic and self-reported medical history of the survey respondents. The mean age of survey respondents was 65 years (range, 34 to 90). The median time to complete the survey was 22 minutes (range, 5 to 5,536) for 28 questions and 13 choices.
A majority of the survey respondents (136 of 224, 60.7%) had prior coronary revascularization. Of these, 98 (43.8%) reported previous PCI with stent placement; 63 (28.1%) had previously undergone CABG. Twenty-five (11.2%) of the survey respondents had undergone both PCI and CABG in the past.
Overall, the respondents were familiar with the con- Fig  1) . Together, the MACCE elements accounted for 66% of the total weight. Risk of death was most important (relative weight 0.23; SE 0.010), followed by stroke (0.18; SE 0.008), myocardial infarction (0.14; SE 0.007), and risk of repeat revascularization (0.11; SE 0.004). The weights of the non-MACCE elements, potential increased longevity and recovery time, accounted for 34% of the total. The weights for these two attributes were equal, each 0.17 (SE 0.008 and SE 0.009, respectively). Respondents with greater aversion to death tended to be women, nonwhite, living alone, poorer, and reporting problems with self-care. Table 3 contrasts the effect of using equal weights for the attributes versus applying the empirical weights to the SYNTAX outcome data for the left main and threevessel disease cohort. The normalized relative weights were used to calculate an adjusted difference between the PCI and CABG cohorts. The equally weighted difference sum was 13.0% in favor of CABG, whereas the adjusted sum was 10.0% in favor of CABG.
The last two choices involved procedures whose attributes reflect current information on PCI and CABG. The first of these mimicked the 11 previous choices, labeling them simply as alternatives A and B, whereas the second choice labeled the options as a "coronary stent procedure" and "coronary bypass procedure." This labeling influenced respondents' choices. When asked to choose between procedures labeled as "procedure A" and "procedure B," 13% of respondents chose the option corresponding to PCI, and 87% chose the option corresponding to CABG. In this abstract task, respondents more likely to choose CABG over PCI included those who valued longevity, reported less concern with hospital stays, were familiar with CABG, and unfamiliar with PCI. In addition, they were more likely to have a lower income and to rent versus own their home.
When the identical choices were later presented with the labels "coronary stent procedure" and "coronary bypass procedure," the proportion of respondents who chose PCI over CABG increased from 13% to 27%. Those who switched from CABG to PCI tended to be younger, male, nonwhite, and more likely to say they were depressed. Further, these respondents also were more likely to have reported a personal history of coronary artery disease and had undergone PCI but not CABG.
These previous analyses involved a forced choice, where respondents had to choose between CABG and
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Expected change in life expectancy over 7 years PCI. When those who chose CABG were asked to assess the likelihood that they would actually proceed with the operation, 61% of respondents reported that they would be "very likely to accept" the procedure. Virtually the same percent, 63% of those who chose PCI, indicated they would very likely comply with the recommendation to undergo the procedure. Overall, only 4.9% of the respondents stated that were "somewhat likely" or "very likely" to decline either procedure. Respondents who had previously undergone CABG or PCI, and were therefore familiar with revascularization, were more likely than others to follow through with a revascularization procedure. Other factors that generally increased the likelihood of compliance included placing a high value on longevity, reporting problems with self-care, and reporting a diagnosis of coronary artery disease but not congestive heart failure.
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Coronary revascularization is one of the most common procedures performed in the United States, with more than 1 million performed each year [5] . Several multicenter, randomized trials, most recently, the Arterial Revascularization Therapies Study II and SYNTAX, have demonstrated superior short-and long-term clinical outcomes for CABG over PCI in patients with multivessel coronary artery disease [3, 6] . Despite this, the proportion of patients undergoing revascularization by CABG has decreased significantly over the past 10 years [7] . A recent study analyzed the performance of PCI in patients with class I indications for CABG, and showed that only 53% of these patients were recommended for CABG by their catheterization laboratory cardiologist [8] .
There are several possible reasons for the decline in use of CABG. There may be a labeling issue similar to what we found. Additionally, negative patient and provider perceptions regarding the risks and invasiveness of surgery, as well as misperception of long-term benefits of PCI compared with CABG, likely influence decision making. Patients are subject to provider bias. A recent study of hospitalized patients reported that the vast majority expressed a desire to have physicians present choices regarding their medical care [9] . Of these, nearly two thirds reported that they would prefer to leave the decision-making to the physician. In other studies, provider specialty has been shown to influence provider preferences for therapy such as operative treatment for breast cancer and lumbar spine surgery [10, 11] . Given this, it is conceivable that patients are subject to bias by their treating physicians, very often cardiologists who perform both diagnostic and therapeutic interventions, when being presented with options for coronary revascularization.
It is also possible that physicians believe that patients desire PCI over CABG. In studies of physicians' perceptions of patient preferences in screening for colorectal cancer and surgical management of esophageal cancer, the relative importance of attributes differed between physicians and patients [12, 13] . Of the six attributes in this study, the risk of death was most important. While it is likely that physicians would also rank death as most important, further study is warranted to determine whether physician perceptions of patient preferences for coronary revascularization are accurate.
In the absence of known relative weights for components of composite endpoints, two trends have become evident in trials comparing cardiac surgical procedures to their transcatheter alternative. First, noninferiority has replaced superiority as the primary statistical test of the composite endpoint, as exemplified by the SYNTAX study and Endovascular Valve Edge-to-Repair Study I [14, 15] . A noninferiority margin is prespecified in part to supplement the composite endpoint for the unmeasured but presumed inherent preference for the percutaneous alternative. However, determining the magnitude of the noninferiority margin in clinical trials is an inexact science at best [16, 17] . Second, it has become common practice to editorialize on the relative importance of the elements of the composite endpoint to reinterpret and redefine the overall study results. For SYNTAX, this occurred within the manuscript and in a simultaneously published editorial where the SYNTAX outcome favoring coronary bypass grafting was contested [15, 18] .
If the composite outcome endpoint elements could incorporate all the important clinical elements and be accurately weighted, trial outcomes would be less subject to post hoc reinterpretation. Accurate weighting, in turn, will necessitate an understanding of the relative importance of the composite elements to the interested parties. While the interested parties include study investigators, study sponsors, payers, and the providers of the thera- [19] and to establish a heart team to determine recommendations for coronary revascularization [20] . This is the first study to explore patient preferences in coronary revascularization procedures. Together, the six attributes examined comprehensively describe considerations in coronary revascularization. The only exception is cost effectiveness, which is fairly neutral in comparing CABG and PCI for patients with complex disease [21] .
The study indicates that the conventional wisdom considering death to be more important than stroke, myocardial infarction, and repeat coronary revascularization is correct. Importantly, however, the study demonstrates that myocardial infarction is almost as important as stroke as an adverse outcome, and that target vessel revascularization is not a trivial, unimportant event. When these results are applied to the SYNTAX composite outcome, it is clear that CABG remains superior to PCI, in terms of MACCE, for patients with three-vessel coronary artery disease. These results are not vulnerable to interpretation with regard to the relative importance of stroke, myocardial infarction, or target vessel revascularization because empirically determined relative importance is now incorporated into the MACCE value.
This study also confirms that patient perceptions of, and prior experiences with, coronary revascularization procedures influence their choices. In addition, patients may be subject to bias by labels when considering coronary revascularization. By simply labeling the procedures as "coronary stent procedure" and "coronary bypass procedure," the proportion of respondents who chose PCI over CABG increased from 13% to 23%. Prior experiences with coronary revascularization influenced respondents' choices in the survey, indicating that familiarity with PCI and CABG is positive among former patients.
This study has important limitations. The proportion of women in the study is comparable to the relative proportion of women versus men undergoing CABG, as well as those with coronary artery disease in general [22, 23] . However, the proportion of nonwhite respondents in our survey was slightly lower than those in the general population [24] . Since nonwhite respondents were more likely to change their final choice from PCI to CABG when labeled as such, the proportion of those choosing PCI over CABG may be slightly underestimated.
In exploring the SYNTAX study outcomes as an example, we used the equally weighted individual MACCE components to compare to the weight-adjusted MACCE calculated from the weights determined by respondents' choices. The small discrepancy between our calculated MACCE and MACCE difference, compared to the published SYNTAX study results, is because SYNTAX allocated a MACCE event only once even if more than one event occurred in an individual patient. Finally, our conclusions can be criticized in that we did not attempt to directly include attributes such as procedural pain and procedural "invasiveness" that, in many ways, form the foundation for the employment of relatively large noninferiority margins favoring transcatheter therapies. We chose to describe the extent of each procedure and the duration of hospitalization and recovery as an explicit attribute, reasoning that survey respondents would recognize when an open surgical procedure was being considered. The fact that the survey respondents valued longevity and the extent of the procedure equally supports the MACCE superiority of CABG, obviating the need for a "less invasive" statistical offset. The evidence presented that patients value longevity benefit with the same positive magnitude as the negative magnitude of procedural invasiveness suggests that a properly weighted MACCE result in favor of CABG should be definitive.
In conclusion, assigning equal weights to the components of clinical trial composite endpoints may result in inaccurate statistical analysis and potentially alters study conclusions. In this study, when comparing procedures for coronary revascularization, patients at risk for coronary artery disease did not view the MACCE elements as having equal weight. Based on these results, future studies comparing PCI and CABG should consider using a weighted composite endpoint of death, stroke, myocardial infarction, and risk of revascularization for more accurate comparison. These results also indicate that existing clinical evidence be carefully and independently interpreted, bearing the patient's perspective in mind as recommendations for treatment selection are being formulated.
